More accurate MS diagnostics possible

A group of proteins identified by researchers at Stockholm's KTH Royal Institute of Technology could play a role in helping multiple sclerosis patients get more accurate diagnostics about the severity and progress of their disease.

Like other autoimmune diseases, MS is complex and difficult to cure or to mitigate. At SciLifeLab in Stockholm, Peter Nilsson, professor in Proteomics at the School of Biotechnology, leads a group that that is looking for answers in large scale .

By analysing tens of thousands of protein fragments for new autoimmunity , or indicators, the group is identifying proteins that distinguish groups of MS patients according to the severity of the disease and how the disease develops over time. Their progress was published in the June 3 issue of Molecular & Cellular Proteomics.

"A group of 51 proteins have been identified as useful in future research around the diagnosis of MS," Nilsson says. "This is to study the origin of the disease and its development – how severe it will be and how quickly it evolves over time."

As part of the Human Protein Atlas (HPA) project, Nilsson's group has access to more than 38,000 . Nilsson says the HPA offers a unique resource that enables the team, which also includes Burcu Ayoglu, Anna Häggmark, Mohsen Khademi, Tomas Olsson, Mathias Uhlén and Jochen Schwenk, to continue their research with confidence.

"We expect a whole new field of research to open up around autoimmune disease, and with that, new insights," Nilsson says.

Ayoglu, a senior graduate student and researcher on the project, agrees that their work could yield much more knowledge about autoimmune diseases, such as hyperthyroidism, type 1 diabetes, vitiligo, rheumatoid arthritis, Sjogren's syndrome and psoriasis.

"Many autoimmune diseases are very complex and we currently lack complete knowledge of them," she says. "Most likely there are many more indicators to find. Our wide approach – in which we study thousands of proteins – is very suited to studying these ."

add to favorites email to friend print save as pdf

Related Stories

Cancer drug a possible treatment for multiple sclerosis

Feb 21, 2013

(Medical Xpress)—A drug that is currently used for cancer can relieve and slow down the progression of the autoimmune disease multiple sclerosis (MS) in rats, according to a new study published in PLOS ONE. The discovery, which ...

Immune cell death safeguards against autoimmune disease

Sep 06, 2012

Researchers at the Walter and Eliza Hall Institute have discovered that a pair of molecules work together to kill so-called 'self-reactive' immune cells that are programmed to attack the body's own organs. ...

Recommended for you

First case of Ebola diagnosed in US

2 hours ago

The United States has diagnosed its first case of the deadly Ebola virus in a man who became infected in Liberia and traveled to Texas, US health officials said Tuesday.

Study finds acupuncture does not improve chronic knee pain

4 hours ago

Among patients older than 50 years with moderate to severe chronic knee pain, neither laser nor needle acupuncture provided greater benefit on pain or function compared to sham laser acupuncture, according to a study in the ...

Ebola outbreak nears end in Nigeria

4 hours ago

The Ebola outbreak in Nigeria is almost over, US health officials said Tuesday, in a rare sign of authorities turning the tide on the highly contagious disease that has killed more than 3,000 in West Africa.

User comments